Tower MSA Partners Releases First-Ever Workers’ Compensation Medicare Secondary Payer (MSP) Outcomes & Regulatory Insights Report

Report is one of the most comprehensive, multi-year MSP outcomes analyses available in the industry

DELRAY BEACH, Fla.--(BUSINESS WIRE)--Tower MSA Partners, an industry-leading provider of Medicare Secondary Payer (MSP) compliance and Medicare Set-Aside (MSA) services, today released the first-of-its-kind Workers’ Compensation Medicare Secondary Payer Outcomes & Regulatory Insights Report to serve as a benchmark for industry stakeholders evaluating their MSP strategy.

The comprehensive report was created utilizing a wide range of aggregated, anonymized performance metrics from 2022–2025 that combine clinical engagement, disciplined allocation methodology, CMS alignment controls, pharmacy mitigation strategy, and conditional payment resolution.

Loaded with impressive, quantifiable statistics and data, the report demonstrates that clients can experience significant MSA-related cost savings when a strong MSP strategy is in place. For instance, the report highlights that Tower’s services, including physician follow-up and pharmacy optimization, produced an average 47% reduction in MSA amounts in 2025, with annual reductions ranging from 33–64% from 2022 to 2025.

“Between 2022 and 2025, Tower MSA Partners delivered measurable, repeatable reductions in Medicare-related settlement exposure for workers’ compensation programs even when CMS MSA approval is required,” said Tower Chief Compliance Officer Daniel Anders. “This report demonstrates that MSP strategy can lead to significant benefits such as better control over allocated medications, quicker CMS MSA approval times, and an overall lower allocation for future medical care.”

Other key Tower outcomes in the report include:

• Total MSA-related cost savings: Clinical interventions generated more than $9 million in savings in 2025 and approximately $9–12 million annually across the 2022–2025 period

• Lower CMS-approved MSAs versus CMS averages: Tower’s MSA preparation, mitigation and submission process resulted in CMS-approved MSAs that were 23% lower than the average CMS-approved MSA across all MSAs submitted to CMS

• Pharmacy and opioid outcomes: In 2025, 60% of CMS-approved Tower MSAs had $0 in Rx and 86% had $0 in opioids, with similarly high levels across 2022–2025

• Process efficiency and appeals: MSA preparation turnaround time was consistently three days from receipt of complete documentation in 2022–2025, and CMS re-review appeals yielded success rates of 63–72% early in the period and 41–45% in 2024–2025

The 16-page report is broken down into five meticulously detailed sections: (1) Regulatory & Market Overview; (2) Tower Outcomes & Key Metrics; (3) Strategic Implications for Workers’ Compensation Programs; (4) Methodology; and (5) Next Steps for Workers’ Compensation Programs.

“This report essentially serves as a roadmap for the workers’ compensation industry,” said Anders. “MSP is no longer a technical compliance exercise – it is a lever that can be pulled to materially influence claim closure. We are honored to provide the entire industry with this tool, and we look forward to partnering with industry professionals who want to begin experiencing the benefits of a disciplined MSP framework.”

ABOUT TOWER MSA PARTNERS

Tower MSA Partners is an industry-leading provider of Medicare Secondary Payer (MSP) compliance and Medicare Set-Aside (MSA) services. The company partners with insurers, self-insured employers, third-party administrators (TPAs), and attorneys to reduce claim costs, mitigate risks, and expedite workers' compensation and liability settlements.

Tower uses a proprietary MSP Automation Suite technology platform to help claims teams navigate complicated government regulations. Core service areas include CMS-compliant MSA allocations and cost-reduction strategies; resolving conditional payment demands and Medicare Advantage plan liens; assisting clients with mandatory CMS Section 111 reporting; and working to settle stagnant legacy claims.

To learn more, visit towermsa.com or follow us on LinkedIn.